Bat Those Lashes
Our lash enhancement treatments give you dramatic eyelashes that will take you from fine to fabulous. Whether you want a temporary treatment, like our lash tinting (we also offer brow tinting), or something more permanent like LATISSE®, we can help.
Lash & Brow Tinting: Before & After Photos
LATISSE®: Before & After Photos
LATISSE® solution is the only FDA-approved product designed to treat the problem of thinning lashes as you age. This prescription treatment is for those who suffer from the condition of inadequate or not enough lashes (formally known as hypotrichosis) and will grow your eyelashes longer, fuller and darker. In fact, LATISSE® will more than double your lash fullness in 16 weeks.*
LATISSE iLash Studio App – See what a difference fuller lashes can make! Check out this free app for iPhones and iPads.
Frequently Asked Questions
How does it work?
The active ingredient in LATISSE® is bimatoprost ophthalmic solution. Bimatoprost ophthalmic solution is a solution in liquid form that is commonly injected in the eye to treat eye pressure. When injected into the upper eyelid where the eyelashes grow, LATISSE® stimulates hair growth, resulting in a noticeable increase in length, thickness, and darkness.*
How long do the results last?
The results from LATISSE® last as long as you continue treatment. They are significant upon 8 weeks after treatment start date. Effects gradually return to your baseline eyelash level upon discontinuation.*
How is it administered?
Since you will be applying it at home, follow instructions carefully. Remove all makeup and contact lenses from the eyes. Add one drop of LATISSE® to the applicator and then apply evenly to the skin on the upper eyelid (not lower) where eyelashes grow. The eyelash area should feel moist but not runny. Dispose of the applicator and grab another one to repeat the process on the other upper eyelid. Make sure to tissue off any runoff that occurs!
How many treatments will I need?
You will need to apply LATISSE® nightly for 16 weeks straight to receive optimal effects. You can also choose an 8 or 12 week period for less prounounced effects.*
Are there any side effects?
LATISSE® is safe if used as intended. The risk for adverse side effects is low. One possible effect of using LATISSE® is pigmentation of the iris or eyelid. When on the iris, it is likely permanent, although coloration of the eyelid can be reversible.* More common side effects include, but are not limited to, hair growth outside the treatment area, decrease in intraocular pressure, and macular edema.
*Results will vary in each individual.
LATISSE® (bimatoprost ophthalmic solution) 0.03% Important Information
LATISSE® (bimatoprost ophthalmic solution) 0.03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness.
Important Safety Information
Warnings and Precautions: In patients using LUMIGAN® (bimatoprost ophthalmic solution) or other prostaglandin analogs for the treatment of elevated intraocular pressure (IOP), the concomitant use of LATISSE® may interfere with the desired reduction in IOP. Patients using prostaglandin analogs including LUMIGAN® for IOP reduction should only use LATISSE® after consulting with their physician and should be monitored for changes to their intraocular pressure.
Increased iris pigmentation has occurred when bimatoprost solution was administered. Patients should be advised about the potential for increased brown iris pigmentation, which is likely to be permanent.
Bimatoprost has been reported to cause pigment changes (darkening) to periorbital pigmented tissues and eyelashes. The pigmentation is expected to increase as long as bimatoprost is administered, but has been reported to be reversible upon discontinuation of bimatoprost in most patients.
There is the potential for hair growth to occur in areas where LATISSE® solution comes in repeated contact with skin surfaces. Apply LATISSE® only to the skin of the upper eyelid margin at the base of the eyelashes.
LATISSE® solution should be used with caution in patients with active intraocular inflammation (eg, uveitis) because the inflammation may be exacerbated.
Adverse Reactions: The most frequently reported adverse events were eye pruritus, conjunctival hyperemia, skin hyperpigmentation, ocular irritation, dry eye symptoms, and erythema of the eyelid. These events occurred in less than 4% of patients.
Postmarketing Experience: The following reactions have been identified during postmarketing use of LATISSE® in clinical practice: burning sensation (eyelid), erythema periorbital, eye swelling, eyelid irritation, eyelid edema, eyelid pruritus, iris hyperpigmentation, lacrimation increased, madarosis and trichorrhexis (temporary loss of a few eyelashes to loss of sections of eyelashes, and temporary eyelash breakage, respectively), rash (including macular, erythematous, and pruritic limited to the eyelids and periorbital region), skin discoloration (periorbital), and vision blurred.
Use in Specific Populations: Use in pediatric patients below the age of 16 years is not recommended because of potential safety concerns related to increased pigmentation following long-term chronic use.
Click here for full LATISSE® Prescribing Information.